Literature DB >> 29335823

[Drugs for intravenous induction of anesthesia: propofol].

D Bolkenius1, C Dumps2, E Halbeck2.   

Abstract

In a series of articles dealing with hypnotics for induction of anesthesia, this article describes the development and current value of propofol. Its significance far exceeds that of a pure induction hypnotic (sedation in diagnostic and therapeutic procedures and on the intensive care unit). Propofol is also used for sedation in diagnostic and therapeutic procedures and on the intensive care unit. In the field of induction of anesthesia, the alternatives are barely used. Some contraindications are still controversial whereas others are no longer sufficiently anchored in the users' awareness (widespread off-label use). Adverse effects, such as injection pain, infection risk and propofol-related infusion syndrome (PRIS) could be significantly reduced by pharmacovigilance. With appropriate caution nearly the whole spectrum of anesthesiology patients can be treated using propofol. The hemodynamic side effects and the rare but potentially fatal PRIS are limitations. Further developments address the water solubility and the solubilizing agents of propofol.

Entities:  

Keywords:  Drug-related side effects and adverse reactions; Off-label use; Pharmacodynamics; Pharmacokinetics; Propofol infusion syndrome

Mesh:

Substances:

Year:  2018        PMID: 29335823     DOI: 10.1007/s00101-017-0397-y

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  55 in total

Review 1.  Intravenous anesthesia for thoracic procedures.

Authors:  Ron V Purugganan
Journal:  Curr Opin Anaesthesiol       Date:  2008-02       Impact factor: 2.706

2.  Comparison of etomidate, ketamine, midazolam, propofol, and thiopental on function and metabolism of isolated hearts.

Authors:  D F Stowe; Z J Bosnjak; J P Kampine
Journal:  Anesth Analg       Date:  1992-04       Impact factor: 5.108

3.  Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.

Authors:  M H Court; S X Duan; L M Hesse; K Venkatakrishnan; D J Greenblatt
Journal:  Anesthesiology       Date:  2001-01       Impact factor: 7.892

Review 4.  When one drug affects 2 patients: a review of medication for the management of nonlabor-related pain, sedation, infection, and hypertension in the hospitalized pregnant patient.

Authors:  Marilyn N Bulloch; Dana G Carroll
Journal:  J Pharm Pract       Date:  2012-04-27

Review 5.  Anaesthetics as cardioprotectants: translatability and mechanism.

Authors:  C Kikuchi; S Dosenovic; M Bienengraeber
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

6.  Cerebral and systemic hemodynamic effects of intravenous bolus administration of propofol in neonates.

Authors:  Joke Vanderhaegen; Gunnar Naulaers; Sabine Van Huffel; Christine Vanhole; Karel Allegaert
Journal:  Neonatology       Date:  2009-12-24       Impact factor: 4.035

Review 7.  The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties.

Authors:  Yoshinori Kotani; Masamitsu Shimazawa; Shinichi Yoshimura; Toru Iwama; Hideaki Hara
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 8.  Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons.

Authors:  Ilkka Parviainen; Reetta Kälviäinen; Esko Ruokonen
Journal:  Neurol Res       Date:  2007-10       Impact factor: 2.448

Review 9.  The pharmacology of propofol.

Authors:  M A Skues; C Prys-Roberts
Journal:  J Clin Anesth       Date:  1989       Impact factor: 9.452

Review 10.  Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports.

Authors:  Adéla Krajčová; Petr Waldauf; Michal Anděl; František Duška
Journal:  Crit Care       Date:  2015-11-12       Impact factor: 9.097

View more
  4 in total

1.  [67-year-old male in resuscitation room for treatment after traffic accident : Preparation for the medical specialist examination: Part 7].

Authors:  C Dumps; D Bolkenius
Journal:  Anaesthesist       Date:  2019-04       Impact factor: 1.041

2.  Measuring the accuracy of propofol target-controlled infusion (TCI) before and after surgery with major blood loss.

Authors:  Thomas Mohler; JoEllen Welter; Martina Steurer; Luis Neumann; Max Zueger; Thomas Kraemer; Alexander Dullenkopf
Journal:  J Clin Monit Comput       Date:  2019-01-22       Impact factor: 2.502

3.  Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway.

Authors:  Yong Xiao; Lifang Zhou; Youbing Tu; Yuantao Li; Yubing Liang; Xu Zhang; Jing Lv; Yu Zhong; Yubo Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-28       Impact factor: 2.570

4.  Postoperative nausea and vomiting in bariatric surgery in comparison to non-bariatric gastric surgery.

Authors:  Philipp Groene; Jana Eisenlohr; Catharina Zeuzem; Sara Dudok; Konrad Karcz; Klaus Hofmann-Kiefer
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-10-03       Impact factor: 1.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.